These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26448434)

  • 1. Identification of High-Risk Plaques by MRI and Fluorescence Imaging in a Rabbit Model of Atherothrombosis.
    Hua N; Baik F; Pham T; Phinikaridou A; Giordano N; Friedman B; Whitney M; Nguyen QT; Tsien RY; Hamilton JA
    PLoS One; 2015; 10(10):e0139833. PubMed ID: 26448434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity.
    Olson ES; Whitney MA; Friedman B; Aguilera TA; Crisp JL; Baik FM; Jiang T; Baird SM; Tsimikas S; Tsien RY; Nguyen QT
    Integr Biol (Camb); 2012 Jun; 4(6):595-605. PubMed ID: 22534729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early in vivo discrimination of vulnerable atherosclerotic plaques that disrupt: A serial MRI study.
    Pham TA; Hua N; Phinikaridou A; Killiany R; Hamilton J
    Atherosclerosis; 2016 Jan; 244():101-7. PubMed ID: 26606442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
    Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
    Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green.
    Ikeda H; Ishii A; Sano K; Chihara H; Arai D; Abekura Y; Nishi H; Ono M; Saji H; Miyamoto S
    Atherosclerosis; 2018 Aug; 275():1-10. PubMed ID: 29852399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo detection of vulnerable atherosclerotic plaque by MRI in a rabbit model.
    Phinikaridou A; Ruberg FL; Hallock KJ; Qiao Y; Hua N; Viereck J; Hamilton JA
    Circ Cardiovasc Imaging; 2010 May; 3(3):323-32. PubMed ID: 20194634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regions of low endothelial shear stress colocalize with positive vascular remodeling and atherosclerotic plaque disruption: an in vivo magnetic resonance imaging study.
    Phinikaridou A; Hua N; Pham T; Hamilton JA
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):302-10. PubMed ID: 23357244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach.
    Lancelot E; Amirbekian V; Brigger I; Raynaud JS; Ballet S; David C; Rousseaux O; Le Greneur S; Port M; Lijnen HR; Bruneval P; Michel JB; Ouimet T; Roques B; Amirbekian S; Hyafil F; Vucic E; Aguinaldo JG; Corot C; Fayad ZA
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):425-32. PubMed ID: 18258820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of MMP activity in postischemic cardiac remodeling using radiolabeled MMP-2/9 activatable peptide probes.
    van Duijnhoven SM; Robillard MS; Hermann S; Kuhlmann MT; Schäfers M; Nicolay K; Grüll H
    Mol Pharm; 2014 May; 11(5):1415-23. PubMed ID: 24641497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases.
    Hyafil F; Vucic E; Cornily JC; Sharma R; Amirbekian V; Blackwell F; Lancelot E; Corot C; Fuster V; Galis ZS; Feldman LJ; Fayad ZA
    Eur Heart J; 2011 Jun; 32(12):1561-71. PubMed ID: 21118852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging features of vulnerable plaques in an atherosclerotic rabbit model.
    Zhao XC; Zhao QM; Ma XH; Zeng CH; Feng TT; Zhao X; Zhang ZQ; Zhang MD; Zhuang XC
    Chin Med J (Engl); 2013; 126(11):2163-7. PubMed ID: 23769577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Vulnerable Atherosclerotic Plaque in Rabbits Using DMSA-USPIO Enhanced Magnetic Resonance Imaging to Investigate the Effect of Atorvastatin.
    Qi C; Deng L; Li D; Wu W; Gong L; Li Y; Zhang Q; Zhang T; Zhang C; Zhang Y
    PLoS One; 2015; 10(5):e0125677. PubMed ID: 25973795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatio-temporal texture (SpTeT) for distinguishing vulnerable from stable atherosclerotic plaque on dynamic contrast enhancement (DCE) MRI in a rabbit model.
    Wan T; Madabhushi A; Phinikaridou A; Hamilton JA; Hua N; Pham T; Danagoulian J; Kleiman R; Buckler AJ
    Med Phys; 2014 Apr; 41(4):042303. PubMed ID: 24694153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Vulnerable Atherosclerotic Plaques in Experimental Atherosclerosis with the USPIO-Enhanced MRI.
    Qi CM; Du L; Wu WH; Li DY; Hao J; Gong L; Deng L; Zhang T; Zhang C; Zhang Y
    Cell Biochem Biophys; 2015 Nov; 73(2):331-337. PubMed ID: 27352319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment.
    Liu C; Zhang X; Song Y; Wang Y; Zhang F; Zhang Y; Zhang Y; Lan X
    Atherosclerosis; 2016 Nov; 254():263-270. PubMed ID: 27680307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation.
    van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
    J Nucl Med; 2011 Feb; 52(2):279-86. PubMed ID: 21233187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo biodistribution of radiolabeled MMP-2/9 activatable cell-penetrating peptide probes in tumor-bearing mice.
    van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
    Contrast Media Mol Imaging; 2015; 10(1):59-66. PubMed ID: 24823643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
    Li X; Bauer W; Israel I; Kreissl MC; Weirather J; Richter D; Bauer E; Herold V; Jakob P; Buck A; Frantz S; Samnick S
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1661-7. PubMed ID: 24903095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging of atherosclerotic aorta of rabbit model by detection of plaque inflammation with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography.
    Zhao QM; Feng TT; Zhao X; Xu ZM; Liu Y; Li DP; Li LQ; Su G; Zhang XX
    Chin Med J (Engl); 2011 Mar; 124(6):911-7. PubMed ID: 21518602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.